
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
![]() | Hikari Food Service Co Ltd | 0.00 | 0.00 | 0.00% | 0 |
![]() | Higashinihon Jisho Co Ltd | 0.00 | 0.00 | 0.00% | 0 |
![]() | MIRAIT One Corporation | 0.00 | 0.00 | 0.00% | 0 |
![]() | JINJIB Co Ltd | 0.00 | 0.00 | 0.00% | 0 |
![]() | Cocolive Inc | 0.00 | 0.00 | 0.00% | 0 |
![]() | Vrain Solution Inc | 0.00 | 0.00 | 0.00% | 0 |
![]() | CCN Group Corp | 0.00 | 0.00 | 0.00% | 0 |
![]() | IN Holdings Co Ltd | 0.00 | 0.00 | 0.00% | 0 |
![]() | Nissui Corporation | 0.00 | 0.00 | 0.00% | 0 |
![]() | UPraise Inc | 0.00 | 0.00 | 0.00% | 0 |
![]() | Veritas In Silico Inc | 0.00 | 0.00 | 0.00% | 0 |
LOUISVILLE, Colo., Feb. 24, 2025 /CNW/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a market leader in hemp extract wellness products, is pleased to announce that the U.S. Food and Drug Administration (FDA) has completed its review of Phase 1 data and Investigational New Drug (IND) application submitted by DeFloria, Inc. ("DeFloria"). The FDA has concluded that DeFloria may now proceed with its planned FDA Phase 2 clinical trial for its botanical pharmaceutical candidate, AJA001 Oral Solution, a treatment for symptoms of autism spectrum disorder (ASD).
VANCOUVER, BC, Feb. 21, 2025 /CNW/ - (TSX: LUC) (BSE: LUC) (Nasdaq FNGM: LUC) PDF Version Lucara Diamond Corp. ("Lucara" or the "Company") today reports its results for the year ended December 31, 2024. All amounts are in U.S. dollars unless otherwise noted.
VANCOUVER, BC, Feb. 23, 2025 /CNW/ - Orezone Gold Corporation (TSX: ORE) (OTCQX: ORZCF) (the "Company" or "Orezone") is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. (the "Underwriter"), acting as sole underwriter and bookrunner, pursuant to which the Underwriter has agreed to purchase, on a "bought deal" basis, 42,683,000 common shares of the Company (the "Common Shares") at a price of C$0.82 per Common Share (the "Offering Price"), for aggregate gross proceeds of C$35,000,060 (the "Offering").
QUEBEC CITY, Feb. 24, 2025 /CNW/ - iA Financial Group (TSX: IAG) is hosting an Investor Event today under the theme Ready for more, the iA way. The event will cover updates on growth strategy, with a particular focus on U.S. business operations and key objectives for Canadian units. The event will be held in person and streamed live for virtual attendees.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
![]() | Bitcoin | 88,793.81 | -2,648.37 | -2.90% | 1.74T | 8,044,994,824 |
![]() | Ethereum | 2,401.50 | -113.84 | -4.53% | 286.5B | 5,389,707,800 |
![]() | Tether USD | 0.99949 | -0.00031 | -0.03% | 141.85B | 437,061,204 |
![]() | Ripple | 2.13 | -0.150 | -6.58% | 120.15B | 2,110,068,770 |
![]() | Binance Coin | 605.52 | -9.06 | -1.47% | 94.81B | 308,943,557 |
![]() | Solana | 137.92 | -4.13 | -2.91% | 65.92B | 2,587,328,527 |
![]() | USD Coin | 0.9999 | -0.00008 | -0.01% | 56.1B | 2,070,347,521 |
![]() | Dogecoin | 0.20312 | -0.00741 | -3.52% | 29.48B | 774,452,146 |
![]() | Cardano | 0.6484 | -0.0334 | -4.90% | 22.78B | 290,834,675 |
![]() | stETH | 2,395.14 | -118.44 | -4.71% | 22.29B | 17,244,256 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions